Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

EXODIAB/LUDC-IRC: A powerhouse for diabetes research

What are the challenges within diabetes research today? And what are the strenghts of Lund university Diabetes Centre (LUDC) to meet those challenges?

A powerhouse for diabetes research

- Diabetes today is one of the largest global health problems that we have. I think that one of the main challenges we have is to make sure that we consider the patient and make sure we have proper therapies to offer, says Maria Gomez, coordinator LUDC-IRC.

Flemming Pociot, Steno Diabetes Centre and member of the scientific advisory board of LUDC-IRC:

- I think one of the major challenges is that we are now recognizing that diabetes is a much more heterogenous disease than we previously anticipated, we have to be much better in phenotyping our patients to treat them the right way. This is one way to aim to a more personalized approach to taking care of our patients. That is a major challenge and I think you are actually world leading in this aspect.

Julia Brosnan, Pfizer and member of the scientific advisory board of LUDC-IRC:

- I think it is really important industry and academia keep talking to each other, we approach drug discovery in different ways that academia looks at the mechanistic ways and industry is trying to apply its problems, and really to do this effectively we need to work togheter why it is important we be here and talk to the investigators is so chritical. As we talk together we learn what the common interest are and how we apply the new biology to the new drug program and drug target we are working on within the industry.

- I think LUDC is a powerhouse for approaching these questions. You have a fantastic research environment and a strong tradition, going from molecule to the bedside to the patient. The setting is very good; you have basic science, you can take care of patients on the same campus, you can very easily translate what you observe in research into that clinical setting, which I think is a good strength of LUDC, Flemming Pociot continues.

- It is a very stimulating environment, we have access to incredible patient cohorts and observational studies and we have gathered al lot of data already and will generate even more data and we have the competence and expertise to interrogate that data in an efficiant way, Maria Gomez concludes.

Text and video: Sara Liedholm

 

 

 

EXODIAB/LUDC-IRC retreat

exodiab/ludc-irc retreat
EXODIAB/LUDC-IRC retreat
Pictures and videos from the retreat and science slam is found on the Intranet.

To the intranet (login)

Latest news

26 October 2018
New findings on intestinal flora development in infants
New findings on intestinal flora development in infants
8 October 2018
New discovery restores insulin cell function in type 2 diabetes
New discovery restores insulin cell function in type 2 diabetes
8 October 2018
New study of babies in Skåne to prevent type 1 diabetes
New study of babies in Skåne to prevent type 1 diabetes
5 October 2018
New function of a key component in the immune system discovered
New function of a key component in the immune system discovered
3 October 2018
International diabetes study receives SEK 40 million to continue
International diabetes study receives SEK 40 million to continue

Lund University Diabetes Centre, CRC, SUS Malmö, Jan Waldenströms gata 35, House 91:12. SE-214 28 Malmö. Telephone: +46 40 39 10 00